Press Release Selective PPARα Modulator “K-808” (Pemafibrate) Granted “Breakthrough Therapy” Designation by the U.S. Food and Drug Administration (FDA) As a Treatment for Primary Biliary Cholangitis
Press Release Headlands Research Expands California Presence with Acquisition of Clinical Trials Research
Press Release Vertafore’s latest AI innovations help agencies accelerate carrier statement reconciliation and turn Outlook activity into structured workflows
Press Release Republic Business Credit Provides $2 Million E-Commerce ABL Facility to Emerging Retailer
Press Release MANTL Surpasses $40 Billion in Deposits Raised on the Platform and Saves Financial Institutions More Than 1 Million Hours on Account Opening
